SARAH CAUDILL: Open Payments
NPI 1831574094 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 14 payments from 11 companies in 2025. Trend: 2023 $295 · 2024 $186 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 2 | $64 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Getinge USA Sales, LLC | 1 | $37 |
| Alnylam Pharmaceuticals Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 2 | $30 |
| bioMerieux Inc | 1 | $28 |
| Novo Nordisk Inc | 1 | $27 |
| AtriCure, Inc. | 1 | $26 |
| ABIOMED | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: VERQUVO, CARDIOROOT, Edwards SAPIEN 3 Ultra Transcatheter Heart Valve, AMVUTTRA, SAPIEN 3 Ultra RESILIA, LEQVIO, Ozempic, ATRICLIP LAA EXCLUSION SYSTEM.
Industry payments across IN — which companies pay providers there.
